Abacus Life and Lorisco Life Announce Launch Of PREADISAN To Improve Health Predictions
Portfolio Pulse from Benzinga Newsdesk
Abacus Life, Inc. (NASDAQ: ABL) and Lorisco Life LLC have announced the launch of PREADISAN™, a health prediction platform that uses machine learning and proteomics to improve health predictions. This partnership aims to enhance Abacus' longevity and actuarial technology services by providing more personalized risk scores.
August 19, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Abacus Life, Inc. (NASDAQ: ABL) has partnered with Lorisco Life LLC to launch PREADISAN™, a health prediction platform that uses machine learning and proteomics. This new product is expected to enhance Abacus' longevity and actuarial technology services, potentially increasing its value proposition to clients.
The launch of PREADISAN™ is a significant development for Abacus Life, as it leverages advanced technologies to improve its service offerings. This could attract more clients and enhance the company's market position, likely leading to a positive short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100